KurtCDemelMD
Oncology • Saint Paul, MNAssistant Professor, Medicine, University of Minnesota Medical School, Minneapolis
Are you Dr. Demel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
640 Jackson St
Saint Paul, MN 55101Phone+1 651-254-3448Fax+1 651-254-3470
Summary
- Dr. Kurt Demel, MD is an oncologist in Saint Paul, Minnesota. He is currently licensed to practice medicine in Minnesota, Wisconsin, and Rhode Island. He is affiliated with Regions Hospital, Abbott Northwestern Hospital, and North Memorial Health Hospital.
Education & Training
Brown UniversityFellowship, Hematology and Medical Oncology, 2003 - 2006
Christ HospitalResidency, Internal Medicine, 2000 - 2002
University of WashingtonResidency, Radiation Oncology, 1999 - 2000- Christ HospitalInternship, Internal Medicine, 1998 - 1999
University of Cincinnati College of MedicineClass of 1998
Certifications & Licensure
MN State Medical License 2006 - 2025
OH State Medical License 1999 - 2025
WI State Medical License 2006 - 2025
RI State Medical License 2003 - 2006
WA State Medical License 1999 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 17 citationsSynchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.Lewis Glasser, Aurelia Meloni-Ehrig, Wesley Olando Greaves, Kurt C. Demel, James N. Butera
Transfusion. 2009-03-01 - 68 citationsAnti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model.Ursula Reusch, Magesh Sundaram, Pamela A. Davol, Sarah D. Olson, James B. Davis
Clinical Cancer Research. 2006-01-01 - 33 citationsLack of bleeding in patients with severe factor VII deficiencyJ. Mark Barnett, Kurt C. Demel, Anthony Mega, James N. Butera, Joseph D. Sweeney
American Journal of Hematology. 2005-02-01
Professional Memberships
- Member
Other Languages
- German
